LifeProNow

MARCH 27, 2023

March 24,2023: “At its annual Pharma Media Day 2023, Bayer presented the latest progress in the ongoing transformation of its pharmaceutical business focusing on accelerating innovative healthcare solutions for the benefits of patients and delivering long-term, sustainable business growth.

Bioethics 130

Bioethics Compounding Diabetes 130

Express Pharma

DECEMBER 7, 2023

However, in this promising landscape, it is imperative for the industry to embrace a paradigm shift from a conventional, volume-based business strategy to a value-driven approach. Key stakeholders, industry leaders, policymakers and innovators came together to drive discussions that will shape the trajectory of India Pharma Inc.

Packaging 95

Packaging Biosimilars 95

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. Ensuring data integrity in the life science industry is crucial for regulatory compliance. Use of advanced technologies.

Documentation 92

Documentation Data Entry Communication Compounding 92

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. It’s a must for the industry. Implementing modular content.

Communication 97

Communication Pharmaceutical Companies Pharmaceutical Companies 97

pharmaphorum

MAY 16, 2022

Adele Waugaman, senior digital health coordinator of the COVID-19 response at the United States Agency for International Development (USAID), tells us what the agency focuses on to strengthen digital health infrastructure globally and improve and expand healthcare access. Digital Strategy and Digital Health Vision.

Documentation 116

Documentation Vaccines 116

pharmaphorum

DECEMBER 9, 2021

If the UK creates regulatory frameworks that drastically diverge from those of its “science allies”, it could become a late – or even no – launch market for new treatments. The vision paper focuses on how to boost the “global competitiveness” of the UK’s life sciences, and make it a “go-to destination for innovation”.

Vaccines 98

Vaccines 98

Pharmaceutical Technology

NOVEMBER 4, 2022

Amidst this, the UK pharmaceutical industry has its own unique set of issues that a head of state will need to tackle in order to support growth and innovation. For the life sciences and pharmaceutical sector, the Conservative government promised £34 billion ($38.98 Consistent government action needed. This would come from “£16.3

Documentation 93

Documentation Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

MAY 6, 2022

For life science companies around the world, enabling faster access to innovative drugs and therapies is a complicated challenge. Closing the digital expectation gap in pharma. Combination pricing: access to the future of oncology treatment. Subscribe to future issues of Deep Dive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JULY 16, 2021

Debiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides to improve patient outcomes. The weight of expectation hangs heavy over the digital health sector. The post Enabling healthcare’s digital future appeared first on.

40

40

Express Pharma

NOVEMBER 3, 2023

The pharma sector is slowly shedding its image as a digital laggard. The jolt from the COVID pandemic saw many companies hasten their digital transformation journey. So what are the best practices and learnings of these pharma digital torchbearers? Many of the early birds are tasting the low-hanging fruits of these forays.

Packaging 110

Packaging Dosage Communication 110

pharmaphorum

JULY 8, 2022

A recent Science 37 survey noted that nearly three-quarters (73%) of respondents from the pharma industry were planning a hybrid or DCT, up from 49% in 2021. Significant opportunities exist for pharma to partner with technologists to leverage digital and sensor technologies to drive further time-and cost-efficiencies in clinical trials.

Drug Development 99

Drug Development Diabetes 99

PharmaShots

FEBRUARY 16, 2023

Suresh Kannan: This latest semi-annual platform update brings innovative revenue optimization and compliance solutions to our high-tech and life sciences customers, including pharmaceutical manufacturers. We’ve aimed our latest product innovations to power customers’ profitability and business growth.

Communication 40

Communication Pharmaceutical Manufacturing Hospitals 40

pharmaphorum

APRIL 11, 2022

Dudley Tabakin, CEO of VivoSense, describes how this financing is set to accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments. We were really searching for the right investment in this emerging digital space. Exploring the wider impact on digital healthcare.

Pharmaceutical Companies 109

Pharmaceutical Companies Pharmaceutical Companies Drug Development Packaging 109

pharmaphorum

NOVEMBER 25, 2021

Now, as face-to-face engagement returns to the agenda, all eyes are on the future shape of pharma events as the world starts to navigate its way out of pandemic conditions. Rethinking pharma’s events’ strategy. A common first step for digital meetings was often to take what was used to occur face-to-face and put it online.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

APRIL 28, 2021

Eric Gilbert explores how data science techniques like text mining are speeding up research into areas such as pancreatic cancer. As a result, many researchers and organisations are relying more on digital technologies and data science techniques to help break down and digest the information available.

Immunity 104

Immunity Immunization 104

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare.

Health and Personal Care Stores 141

Health and Personal Care Stores Medication Guidelines Communication 141

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Communication 98

Communication 98

pharmaphorum

OCTOBER 19, 2020

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. In the past, our collective adoption of, and trust in, digital technology has been incremental and often reluctant.

Diabetes 127

Diabetes Communication Hospitals 127

pharmaphorum

AUGUST 31, 2021

For the innovators and early adopters of the life sciences industry, engineering a regulatory-grade ECA can be daunting. Still, in 2021, we have seen the industry evolve and develop strategies on how to establish a viable ECA. Myth 1: There are too many challenges with adopting an ECA. About the authors.

Insurance Coverage and Processing 89

Insurance Coverage and Processing Drug Development Documentation Labelling 89

pharmaphorum

JULY 1, 2021

Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm’s Tanja Dowe. Chemistry, engineering and computer science will have to play together in a much more integrated way than they have to date.

Drug Development 86

Drug Development Pharmaceutical Companies Pharmaceutical Companies Vaccines 86

pharmaphorum

MAY 18, 2022

While around 70% of epilepsy patients today are well-controlled and largely able to enjoy a ‘normal’ quality of life, either seizure-free or with a much lower frequency of seizures, we are working hard to understand the underlying causes of the symptoms of those remaining 30% who still don’t respond to available therapies,’ explains Charl.

Immunity 92

Immunity Immunization Pharmaceutical Companies Pharmaceutical Companies 92

Quality Matters

MAY 17, 2023

Paradigm Shift in Drug Development: Analytical Quality by Design and Analytical Procedure Life Cycle In today’s pharmaceutical manufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing 52

European Pharmaceutical Review

MARCH 2, 2023

Clinical innovation: using digital solutions to deliver the next wave of medicines Having an agreed model for the data that multiple stakeholders and collaborators can work with is potentially transformational in many ways. In the event of a future pandemic, we would soon see the practical benefits of that improved exchange.

Drug Development 89

Drug Development 89

pharmaphorum

MAY 18, 2021

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma. Pre-commercial companies need to hit the ground running with their launch strategies to be successful,” says Ian Hale, vice president of commercial content at Veeva. “Pre-commercial

Drug Development 52

Drug Development 52

pharmaphorum

JANUARY 27, 2023

She knows only too well how understanding the importance of patient centricity is crucial to the success of any modern life sciences company – but how has the landscape changed since 2019? “I I still feel that it is very important,” Dr Mullen said. “We’ve And this ethos is true of Boyds, as well. “I

Vaccines 109

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 109

Viseven

NOVEMBER 30, 2022

Jay Rabheru , Head of Marketing, Agency Services, Life Science and Healthcare,? A recent pandemic has accelerated a bit more, but still, it requires a certain standard from the digital experience. But we see the increasing need for customers to forge an ecosystem of partnerships, innovate at scale, and be a part of the market.

52

52

pharmaphorum

JUNE 8, 2022

A healthcare consulting firm for more than 20 years, Avalere partners with leading life sciences companies, health plans, providers, and investors to bring innovative, data-driven solutions to complex healthcare challenges. . A technology-enabled partnership . We are delighted to welcome the Avalere team to FH.

Communication 52

Communication 52

Pharmaceutical Technology

OCTOBER 5, 2022

Technology is advancing the possibilities of healthcare treatments, from the development of innovative new drugs to freeing up time for doctors thanks to monitoring devices for patients with conditions such as diabetes and high blood pressure. Moreover, it creates an environment for ongoing innovation and evolution of tools and services.”.

Compounding 52

Compounding Diabetes 52

pharmaphorum

JANUARY 25, 2022

Oskar Möbert, Vice President OpenData Europe at Veeva Systems, tells us how they are reimagining customer reference data to boost pharma rep productivity, enable more personalised engagement, and increase patient reach. “For example, they might want to talk to a nurse, a patient advocate or a digital influencer. . That’s key.

Communication 104

Communication Pharmaceutical Companies Pharmaceutical Companies 104

pharmaphorum

JUNE 11, 2021

Both the breakneck speed and scale of this vaccine generation and distribution were remarkable and encouraging for the future development of treatments for various conditions. These trends combine to increase the pace of innovation and the precision of therapies. Treat them as such. About the author.

Vaccines 109

Vaccines HIPAA Immunity Immunization 109

Viseven

MAY 15, 2023

With the advent of digital marketing, plenty of new forms of online communication emerged and eventually superseded detailing that turned from the most fundamental method of engagement into one of many. One more slide with a simple feedback form added to the end of an e-detailer can dramatically increase customer experience in the future.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development. On the path to better product development.

Communication 123

Communication Drug Development 123

European Pharmaceutical Review

FEBRUARY 21, 2023

“Cannabis is becoming more widely accepted around the world and is being widely researched by many international organisations for medicinal purposes,” acknowledged Dr Jaap Venema, the United States Pharmacopeia (USP)’s Chief Science Officer in September 2022. What are your future predictions for the industry?

Pharmaceutical Companies 131

Pharmaceutical Companies Pharmaceutical Companies Compounding Drug Development 131

pharmaphorum

DECEMBER 14, 2022

As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. Angelini Ventures isn’t a typical corporate venture capital firm.

Drug Development 104

Drug Development 104

pharmaphorum

OCTOBER 6, 2020

But for many life sciences organisations, these tools are either not yet fully adopted or are not being put to good use within their regulatory functions. The Accenture Technology Vision survey found just one-third of 103 life sciences executives have high confidence in their data and validate it extensively.

Documentation 111

Documentation Communication Labelling Data Entry 111

pharmaphorum

MARCH 30, 2021

Alexion’s senior vice president of its international business talks to Paul Tunnah about the importance of “people-centred and vulnerable” leadership, the surprising impacts of COVID and the promising future for treating patients with rare diseases. . Once you start working in rare disease, you get so inspired by the patients.

Hospitals 109

Hospitals Communication Drug Development Pharmaceutical Companies 109

European Pharmaceutical Review

SEPTEMBER 16, 2022

But how will this drive for resilience shape the future of pharmaceutical supply chains? Moreover, Derron Stark, EY Principal, Strategy and Transactions, revealed that depending on the type of product – small molecule versus biologic – the ability to localise supply and thus the overall supply chain strategy differs.

Packaging 91

Packaging Documentation 91